The Clinical Efficacy and Safety of the Sahastara Remedy versus Diclofenac in the Treatment of Osteoarthritis of the Knee: A Double-Blind, Randomized, and Controlled Trial

Table 2

Baseline characteristics of patients.

Data	SHT remedy ()	Diclofenac ()	value
Female, number (%)	28 (90.3)	27 (90)
Age; yrs, mean (SD)	60.38 (6.97)	58.23 (7.99)
Weight; kg., mean (SD)	68.48 (10.64)	65.27 (9.81)
Height; cm., mean (SD)	158.29 (6.38)	157.13 (5.90)
BMI; Kg/m^2, mean (SD)	27.27 (3.69)	26.35 (3.02)
Visual analogue scale (VAS); mm., mean (SD)	44.1 (23.5)	43.5 (19.3)
100-meter walking time; sec., mean (SD)	103.77 (47.51)	103.19 (35.43)
WOMAC index score, mean (SD)
Pain index	8.52 (3.77)	8.47 (2.39)
Stiff index	3.32 (1.92)	3.53 (1.61)
Physical function index	30.64 (11.69)	31.03 (10.77)
Total score	42.65 (15.70)	43.13 (13.69)
Laboratory data, mean (SD)
Blood pressure
Systolic (mm.Hg.)	123.55 (11.42)	121.83 (13.03)
Diastolic (mm.Hg.)	82.90 (8.24)	80.50 (8.13)
Renal function tests
BUN (mg/dL)	13.74 (4.69)	15.35 (4.55)
Creatinine (mg/dL)	0.84 (0.27)	0.80 (0.20)
Liver function tests
AST (U/L)	28 (19.49)	22.33 (10.35)
ALT (U/L)	46.48 (23.94)	40.90 (12.91)
ALP (U/L)	108.26 (25.95)	98.27 (23.26)

Statistical analysis: Student’s -test, chi-square test.